文献速递肝病

肝移植术后多重耐药细菌感染:患病率、影响及危险因素

Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors.
PubMed 文献 · J Hepatol · 2024-02-28

这项回顾性多中心队列研究纳入西班牙9个中心2017年1月至2020年1月间1045例肝移植手术(960例患者),分析肝移植术后90天内多重耐药细菌感染的患病率、预后影响及危险因素。结果显示多重耐药菌分离率为21.7%(227例),独立预测因素包括移植前0-3个月入住ICU、移植前0-3个月多重耐药菌感染及术中输注浓缩红细胞单位数增加,多重耐药菌感染患者30、90、180和365天死亡率显著更高。

要点

  • 肝移植术后多重耐药菌感染常见,227例(21.7%)分离出多重耐药菌。
  • 最常见多重耐药菌为屎肠球菌(22.1%)、大肠埃希菌(18.4%)和铜绿假单胞菌(15.2%)。
  • 移植前0-3个月入住ICU、移植前0-3个月多重耐药菌感染及术中输注浓缩红细胞单位数增加是独立预测因素。

核心结论

  • 多重耐药细菌感染在肝移植术后高度流行,对预后有显著影响,屎肠球菌是最常分离的多重耐药微生物。
  • 作者认为,对于有危险因素的患者,应考虑新的药理学和监测策略以预防肝移植术后多重耐药细菌感染。

研究设计与样本

  • 回顾性、多中心队列研究,纳入2017年1月至2020年1月期间接受肝移植的成年患者。
  • 共纳入西班牙9个中心的1045例肝移植手术(960例患者)。
  • 分析移植前疾病、手术操作和术后住院相关的危险因素,采用多变量逻辑回归分析识别肝移植术后90天内多重耐药细菌感染的独立预测因素。

主要发现

  • 队列平均年龄56.8±9.3岁,男性占75.4%(n=782),酒精相关肝病为最常见基础病因(43.2%,n=451)。
  • 432例患者(41.3%)发生细菌感染,共679次感染发作,包括呼吸道感染19.3%、尿路感染18.5%、菌血症13.2%和胆管炎11%等。
  • 227例肝移植病例(21.7%)分离出多重耐药菌,共348次发作;最常见的分离微生物为屎肠球菌(22.1%)、大肠埃希菌(18.4%)和铜绿假单胞菌(15.2%)。
  • 多变量分析中,移植前0-3个月入住ICU、移植前0-3个月多重耐药菌感染及术中输注浓缩红细胞单位数增加被确定为多重耐药菌感染的独立预测因素。
  • 多重耐药菌分离患者30、90、180和365天死亡率显著更高。

关键数值与推荐

  • 多重耐药菌分离率:227/1045例肝移植病例(21.7%)。
  • 细菌感染发生率:432/1045例患者(41.3%),共679次感染发作。
  • 最常见多重耐药菌:屎肠球菌22.1%、大肠埃希菌18.4%、铜绿假单胞菌15.2%。
  • 独立预测因素:移植前0-3个月入住ICU、移植前0-3个月多重耐药菌感染、术中输注浓缩红细胞单位数增加。

临床怎么用

  • 作者认为,对于有危险因素的患者,应考虑新的药理学和监测策略以预防肝移植术后多重耐药细菌感染。
  • 作者指出,改善预防、早期识别和经验性治疗策略至关重要。
  • 研究结果可为肝移植术后预防性和经验性抗生素治疗方案的制定提供参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Infections by multidrug-resistant bacteria (MDRB) are an increasing healthcare problem worldwide. This study analyzes the incidence, burden, and risk factors associated with MDRB infections after liver transplant(ation) (LT). METHODS: This retrospective, multicenter cohort study included adult patients who underwent LT between January 2017 and January 2020. Risk factors related to pre-LT disease, surgical procedure, and postoperative stay were analyzed. Multivariate logistic regression analysis was performed to identify independent predictors of MDRB infections within the first 90 days after LT. RESULTS: We included 1,045 LT procedures (960 patients) performed at nine centers across Spain. The mean age of our cohort was 56.8 ± 9.3 years; 75.4% (n = 782) were male. Alcohol-related liver disease was the most prevalent underlying etiology (43.2.%, n = 451). Bacterial infections occurred in 432 patients (41.3%) who presented with a total of 679 episodes of infection (respiratory infections, 19.3%; urinary tract infections, 18.5%; bacteremia, 13.2% and cholangitis 11%, among others). MDRB were isolated in 227 LT cases (21.7%) (348 episodes). Enterococcus faecium (22.1%), Escherichia coli (18.4%), and Pseudomonas aeruginosa (15.2%) were the most frequently isolated microorganisms. In multivariate analysis, previous intensive care unit admission (0-3 months before LT), previous MDRB infections (0-3 months before LT), and an increasing number of packed red blood cell units transfused during surgery were identified as independent predictors of MDRB infections. Mortality at 30, 90, 180, and 365 days was significantly higher in patients with MDRB isolates. CONCLUSION: MDRB infections are highly prevalent after LT and have a significant impact on prognosis. Enterococcus faecium is the most frequently isolated multi-resistant microorganism. New pharmacological and surveillance strategies aimed at preventing MDRB infections after LT should be considered for patients with risk factors. IMPACT AND IMPLICATIONS: Multidrug-resistant bacterial infections have a deep impact on morbidity and mortality after liver transplantation. Strategies aimed at improving prophylaxis, early identification, and empirical treatment are paramount. Our study unveiled the prevalence and main risk factors associated with these infections, and demonstrated that gram-positive bacteria, particularly Enterococcus faecium, are frequent in this clinical scenario. These findings provide valuable insights for the development of prophylactic and empirical antibiotic treatment protocols after liver transplantation.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Martin-Mateos R, Martínez-Arenas L, Carvalho-Gomes Á, et al. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors. J Hepatol. 2024. PMID: 38428641. doi:10.1016/j.jhep.2024.02.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。